Aureolic acids from a marine-derived Streptomyces sp. WBF16

Microbiological Research

Volumn 167, Issue 10, 2012, Pages 590-595

  Lu, Jiansheng ^a   Ma, Yihua ^a   Liang, Jianjia ^a   Xing, Yingying ^a   Xi, Tao ^a   Lu, Yuanyuan ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Aureolic acid; Chromomycin; Marine Streptomyces; Phylogenetics analysis; Secondary metabolites

Indexed keywords

16S RDNA SEQUENCE; ANTI-TUMOR ACTIVITIES; CHROMOMYCIN; CHROMOMYCIN A; GENETIC TECHNIQUES; MARINE STREPTOMYCES; PHYLOGENETICS; SECONDARY METABOLITES; SGC7901; SPECTROSCOPIC METHOD; STREPTOMYCES COELICOLOR A3(2); STREPTOMYCES SP;

METABOLITES; SPECTROSCOPIC ANALYSIS;

BACTERIA;

CHROMOMYCIN; MITHRAMYCIN;

ANTIBIOTICS; BACTERIUM; BIOCHEMISTRY; BIOTECHNOLOGY; DISEASE TREATMENT; GENETIC ANALYSIS; MARINE ENVIRONMENT; MEDICINE; MORPHOLOGY; PHYLOGENETICS; RELATEDNESS; SECONDARY METABOLITE; SPECTROSCOPY; TUMOR;

ARTICLE; CELL LINE; CELL STRAIN HCT116; CELL STRAIN HEPG2; CHEMISTRY; CLASSIFICATION; DRUG SCREENING; HUMAN; MARINE BIOLOGY; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STREPTOMYCES; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL LINE; CELL LINE, TUMOR; CHROMOMYCINS; DRUG SCREENING ASSAYS, ANTITUMOR; HCT116 CELLS; HEP G2 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MARINE BIOLOGY; PLICAMYCIN; STREPTOMYCES;

ACTINOBACTERIA; STREPTOMYCES; STREPTOMYCES COELICOLOR; STREPTOMYCES SP.;

EID: 84867899366     PISSN: 09445013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micres.2012.06.001     Document Type: Article

References (35)

1. Calabresi, Chabner The pharmacological basis of therapeutics. The pharmacological basis of therapeutics 1991, 1209-1263. Pergamon Press, New York. T.W. Rall, A.S. Nies, P. Taylor (Eds.).
2. Chun J., Goodfellow M. A phylogenetic analysis of the genus Nocardia with 16S rRNA gene sequences. Int J Syst Evol Microbiol 1995, 45:240-245.
3. Dewick P.M. Medicinal natural products: a biosynthetic approach 1997, John Wiley and Sons, Inc., New York, p. 123-4.
4. Elias E.G., Evans J.T. Mithramycin in the treatment of Paget's disease of bone. Bone Joint Surg 1972, 54:1730-1736.
5. Fibach E., Bianchi N., Borgatti M., Prus E., Gambari R. Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells. Blood 2003, 102:1276-1281.
6. Gottlieb D. An evolution of criteria and procedures used in the description and characterization of Streptomyces, a co-operative study. Appl Microbiol 1961, 9:55-60.
7. Holding A.J., Collee J.G. Routine biochemical tests. Methods Microbiol 1971, 6A:1-31.
8. 2+ coordination. Biochimie 1995, 77:729-738.
9. Hu Y.C., Ewpindola P.D.M., Stewart N.A., Wei S.G., Posner B.A., Macmillan J.B. Chromomycin SA analogs from marine-derived Streptomyces sp. Bioorg Med Chem 2011, 19:5183-5189.
10. Jia Z., Zhang J., Wei D., Wang L., Yuan P., Le X., et al. Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A. Cancer Res 2007, 67:4878-4885.
11. Katahira R., Uosaki Y., Ogawa H., Yamashita Y., Nakano H., Yoshida M. UCH9, a new antitumor antibiotic produced by Streptomyces. II. Structure elucidation of UCH9 by mass and NMR spectroscopy. J Antibiot 1998, 51:267-274.
12. Kennedy B.J., Yarbro J.W., Kickertz V., Sandberg-Wollheim M. Effect of mithramycin on a mouse glioma. Cancer Res 1968, 28:91-97.
13. Kumar S., Tamura K., Jakobsen I.B., Nei M. MEGA 2: molecular evolutionary genetics analysis software. Bioinformatics 2001, 17:1244-1245.
14. Lechevalier H.A., Lechevalier M.P. A critical evaluation of the genera of aerobic actinomycetes. The actinomycetales 1970, Gustav Fischer Verlag, Jena, p. 393-405. H. Prauser (Ed.).
15. Lo Giudice A., Bruni V., Michaud L. Characterization of Antarctic psychrotrophic bacteria with antibacterial activities against terrestrial microorganisms. J Basic Microbiol 2007, 47:496-505.
16. Lombó F., Menéndez N., Salas J.A., Méndez C. The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives. Appl Microbiol Biotechnol 2006, 73:1-14.
17. 4. Tetrabedron 1967, 23:421-437.
18. Ma X.C., Cui J., Zheng J., Guo D.A. Microbial transformation of three bufadienolides by Penicillum aurentigriseum and its application for metabolite identification in rats. J Mol Catal B: Enzym 2007, 48:42-50.
19. Ogawa H., Yamashita Y., Katahira R., Chiba S., Iwasaki T., Ashizawa T., et al. UCH9, a new antitumor antibiotic produced by Streptomyces: I. Producing organism, fermentation, isolation and biological activities. J Antibiot 1998, 51:261-266.
20. Remers W.A. In the chemistry of antitumor antibiotics 1979, vol. 2. Wiley-Interscience, p. 133-75.
21. Remers W.A., Iyengar B.S. In cancer chemotherapeutic agents. Am Chem Soc 1995, 577-679.
22. Remers W.A. The chemistry of antitumor antibiotics 1979, vol. 1. Wiley-Interscience, 1133-41.
23. Saitou N., Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987, 4:406-425.
24. Sastry M., Fiala R., Patel D. Solution structure of mithramycin dimers bound to partially overlapping sites on DNA. J Mol Biol 1995, 251:674-689.
25. Sastry M., Patel D. Solution structure of the mithramycin dimer-DNA complex. Biochemistry 1993, 32:6588-6604.
26. Shirling E.B., Gottlieb D. Methods for characterization of Streptomyces species. Int J Syst Bacteriol 1966, 16:313-340.
27. Skarbek J.D., Speedie M.K. In antitumor compounds of natural origin. Chem Biochem 1981, 1:191-235.
28. Staneck J.L., Roberts G.D. Simplified approach to identification of aerobic actinomycetes by thinlayer chromatography. Appl Microbiol 1974, 28:226-231.
29. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., Higgins D.G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997, 25:4876-4882.
30. Tresner H.D., Hayes J.A., Backus E.J. Differential tolerance of streptomycetes to sodium chloride as a taxonomic aid. Appl Microbiol 1968, 16:1134-1136.
31. Tsuyoshi K., Tomomi H., Kazuo F., Mochizuki J., Hiroshi N., Yoichi H., et al. Isolation and structures of mono- and di-deacetyl chromomycin antibiotics 02-3D and 02-3G from Streptomyces avellaneus. J Antibiot 1990, 8:110-113.
32. Waksman S.A. The Actinomycetes, Classification, Identification and Description of Genera and Species 1961, vol. 2. The Williams and Wilkins Company, Baltimore, pp. 61-292.
33. Watve M.G., Tickoo R., Jog M.M., Bhole B.D. How many antibiotics are produced by the genus Streptomyces. Arch Microbiol 2001, 176:386-390.
34. Weisburg W.G., Barns S.M., Pelletier D.A., Lane D.J. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 1991, 173:697-703.
35. 3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons. Ann Neurol 2001, 49:345-354.